Clario Acquires WCG's eCOA Business
May 6, 2025
Clario has acquired the electronic clinical outcome assessment (eCOA) business of WCG to expand its endpoint data solutions and deepen neuroscience-focused clinical outcomes expertise. The deal—announced in March and completed in May 2025—transfers WCG’s eCOA team and capabilities to Clario and is expected to enhance Clario’s support for complex neuroscience clinical trials.
- Buyers
- Clario
- Targets
- WCG's eCOA business
- Sellers
- WCG
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Thermo Fisher Scientific to Acquire Clario Holdings
October 29, 2025
Healthcare Services
Thermo Fisher Scientific has agreed to acquire Clario Holdings, a digital clinical endpoint data solutions company, for $8.875 billion in cash plus up to $400 million in performance-based earnout payments. The deal is expected to close by mid-2026 pending regulatory approvals and would integrate Clario into Thermo Fisher’s Laboratory Products and Biopharma Services segment.
-
Clario Acquires NeuroRx
March 19, 2025
Healthcare Services
Clario has acquired NeuroRx, a Montreal-based imaging analysis provider specializing in neuroimaging for clinical trials, to strengthen Clario's neuroscience capabilities. NeuroRx founder Douglas Arnold will join Clario as Senior Scientific Advisor as the company integrates NeuroRx's imaging expertise to support drug development in CNS indications.
-
WCG Acquires VeraSci
July 26, 2021
Healthcare Services
WCG acquired VeraSci, a Durham-based provider of eClinical software and specialty scientific expertise for CNS-focused clinical trials, to deepen its CNS scientific capabilities and expand remote data capture and decentralized trial solutions. VeraSci will operate as WCG VeraSci and remain headquartered in North Carolina while retaining its leadership team.
-
WCG Acquires The Avoca Group
May 11, 2021
Healthcare Services
WCG, a provider of clinical trial solutions, has acquired The Avoca Group, a life sciences consulting firm focused on clinical trial quality management, benchmarking and analytics. The acquisition strengthens WCG's capabilities in quality management, benchmarking and compliance to accelerate clinical research and improve trial efficiency.
-
WCG Acquires Trifecta Clinical
December 3, 2020
Healthcare Services
WCG has acquired Trifecta Clinical, a provider of technology-enabled clinical trial site communications and training solutions including the InvestigatorSpace platform. The deal brings Trifecta's investigator training, safety letter distribution and document-exchange capabilities into WCG's suite of clinical research services while Trifecta retains its leadership and offices in Los Angeles and other locations.
-
WIRB-Copernicus Group (WCG) Acquires Velos eResearch
January 24, 2019
Cloud & SaaS
WCG's Clinical Services Division has acquired the Velos eResearch business line, a provider of clinical trial management system (CTMS) software. Velos will operate independently and retain its Fremont, California headquarters while WCG integrates the CTMS capabilities to expand technology offerings for its research customers.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.